The global contrast injection lines market size is likely to be valued at US$ 5.1 Billion in 2022 and exhibit growth at a CAGR of 4.7% in the forecast period from 2022 to 2032. Increasing need to perform MRI, X-Ray, and CT scans is likely to push the demand for contrast injection lines in the upcoming years. According to FMI, the global contrast injection lines market is set to reach US$ 11.2 Billion in 2032.
| Report Attribute | Details |
| Contrast Injection Lines Market Estimated Base Year Value (2021) | US$ 4.3 Billion |
| Contrast Injection Lines Market Expected Market Value (2022) | US$ 5.1 Billion |
| Contrast Injection Lines Market Anticipated Forecast Value (2032) | US$ 11.2 Billion |
| Contrast Injection Lines Market Projected Growth Rate (2022-2032) | 4.7% CAGR |
Contrast injection lines are extensively used to improve images and scans. The contrast dye is inserted through injections in a patient during various diagnostic imaging procedures.
Contrast dye is usually injected through the cannula placed either in the vein or the artery. It is a colorless fluid that is used to propel the contrast of fluids or structures within the body during medical imaging procedures.
The demand for contrast injection lines is projected to surge at a fast pace in the assessment period stoked by their increasing usage during angiographic intervention. The rising number of numerous radiological examination procedures because of the increasing patient pool in various parts of the globe is also set to augment the market.
Rising prevalence of various chronic disorders is likely to spur the sales of contrast injection lines in the forthcoming years. This is attributable to the urgent need for numerous radiological interventional procedures across the globe. Increasing healthcare expenditure, especially in developed countries is another vital factor that is likely to drive the global market.
Moreover, the availability of cost-effective medical care services and devices with the ongoing development of new products is likely to boost the market. High disposable income of people and surging cases of vascular disorders are also anticipated to foster the need for diagnostic imaging procedures, thereby propelling the market.
Various risks, such as nephrogenic systemic fibrosis and contrast induced nephropathy related to the insertion of contrast injection may hamper the market growth. In addition to that, the high cost of contrast media injection depending on the type of injectors can obstruct the demand. In emerging economies, the lack of knowledge about these injections owing to safety and hygiene issues is also projected to hinder the contrast injection lines market growth.
Based on region, North America is projected to lead by procuring the largest contrast injection lines market share in the near future. The rising prevalence of cardiovascular diseases across the U.S. and Canada is anticipated to bolster the regional market. Also, the increasing number of radiological examination and interventional procedures is set to drive the market.
As per the Centers for Disease Control and Prevention (CDC), in the U.S., about 659,000 people die due to heart attack every year, whereas one person dies every 36 seconds in this country from cardiovascular diseases. This trend is likely to continue throughout the forthcoming years, thereby propelling the North America market.
Asia Pacific is likely to remain in the second position in the evaluation period owing to ongoing investments by government bodies to develop the healthcare infrastructure in India and China. The high demand for diagnostic imaging procedures backed by the ever-increasing geriatric population is another crucial factor that is estimated to propel the contrast injection lines market size in future.
Rapid advancement in the field of radiological interventional procedures, such as angiography, computed tomography, and fluoroscopy is also set to propel the regional market. In addition to that, the surging demand for contrast agents in this region to evaluate the accurate body site scans is expected to bode well for the Asia Pacific market.
Some of the renowned companies present in the global contrast injection lines market include Argon Medical Devices Inc., Shenzhen Axwei Medical Technology Co., Ltd., AngioDynamics (Navilyst Medical, Inc.), George Philips Medical Engineering Pvt. Ltd., B. Braun Melsungen AG, Merit Medical Systems, Inc., Dickinson and Company, and Becton among others.
Key players in the market are investing huge sums in research and development activities to come up with novel products and expand their existing portfolios. A few other companies are engaging in joint ventures and acquisitions with healthcare organizations to deliver their in-house products. Meanwhile, a handful of companies are striving to broaden their geographic presence by opening new manufacturing facilities.
| Report Attribute | Details |
| Growth Rate | CAGR of 4.7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global contrast injection lines market is set to exceed US$ 11.2 Billion in 2032.
North America is set to lead the contrast injection lines market in the forecast period.
Argon Medical Devices Inc., Shenzhen Axwei Medical Technology Co., Ltd., AngioDynamics (Navilyst Medical, Inc.), and George Philips Medical Engineering Pvt. Ltd. are some of the renowned companies in the contrast injection lines market.
Explore Similar Insights
Contrast Injection Lines Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
